RUNX3 and pancreatic neoplasm: In conclusion, we have clearly demonstrated for the first time that RUNX3 is frequently methylated in primary pancreatic cancer tissues, frequent hemizygous deletion occurs at its locus in 1p36, and RUNX3-inactivated cases showed worse survival.